Summary
• OneMedNet Corporation’s share price increased by 13.8% to $1.24, attributed to expansion initiatives.
• The company expanded its iRWD™ network by adding 380 provider sites and 13 million unique patient records.
• OneMedNet reported an 815% year-over-year increase in Q3 bookings, indicating strong demand for its services.
OneMedNet Corporation (NASDAQ: ONMD) is experiencing a notable price increase of 13.8%, trading at $1.24 after the close of the previous session. The move follows the company’s recent announcement regarding expansion initiatives, marking a significant improvement in operational metrics.
Network Expansion Fuels Growth Potential
On November 20, 2025, OneMedNet reported substantial growth in its real-world data network. The company added approximately 380 provider sites, expanding its iRWD™ network to over 2,130 locations, which represents a 22% increase in scale. Furthermore, it increased unique de-identified patient records by 13 million, totaling more than 47 million — an increase of 38%. Clinical exams and images also surged by 50 million, bringing the total to over 186 million, marking a 37% growth. This network expansion bolsters OneMedNet’s standing as a leader in the real-world data sector, enhancing its service offerings and potential subscription revenue streams.
Recent Performance Highlights
The recent surge in share price comes amid impressive bookings results. On November 17, 2025, OneMedNet disclosed a staggering 815% year-over-year increase in bookings for the third quarter, totaling $1.1 million. The company has underscored a shift in demand, emphasizing a four and a half times increase in inbound interest for its services. This trend suggests a strong trajectory for future revenue growth, positioning OneMedNet favorably in the competitive landscape.
Technical Analysis and Market Data Snapshot
Trading volume for OneMedNet has been notable, with 174,458 shares exchanged, significantly lower than its average 10-day volume of 1,226,863 and its 3-month average of 6,127,449. The stock’s 52-week high reflects a significant decline at 74.2%, while the year-to-date performance remains positive at an 8.8% increase. Currently, the stock’s price is quite reactive, with an RSI of 30.3, indicating potential momentum shifts as it navigates its recent highs and lows.
Outlook
With OneMedNet’s recent performance and planned growth strategies, investors appear to be reassessing the company’s prospects in the evolving landscape of real-world data. The accelerated expansion of its network can significantly enhance its revenue streams, contributing to a sustained upward trajectory in the stock’s performance.
